APR 13, 2015 08:58 AM PDT

Heart Cells Regenerated, in Mice

WRITTEN BY: Judy O'Rourke
When a heart attack strikes, heart muscle cells die and scar tissue forms, paving the way for heart failure.

Cardiovascular diseases are a major cause of death worldwide, in part because the cells in our most vital organ do not get renewed. As opposed to blood, hair, or skin cells that can renew themselves throughout life, our heart cells cease to divide shortly after birth, and there is very little renewal in adulthood. New research at the Weizmann Institute of Science provides insight into the question of why the mammalian heart fails to regenerate, on one hand, and demonstrates, in adult mice, the possibility of turning back this fate.
Two neonatal cardiomyocytes (stained red) undergoing cell division after treatment with NRG1 are shown.
Professor Eldad Tzahor, PhD, of the Institute's Biological Regulation Department, thought part of the answer to the regeneration puzzle might lie in his area of expertise: embryonic development, especially of the heart. Indeed, it was known that a protein called ERBB2 - which is well studied because it can pass along growth signals promoting certain kinds of cancer - plays a role in heart development. ERBB2 is a specialized receptor - a protein that transmits external messages into the cell. ERBB2 generally works together with a second, related, receptor by binding a growth factor called Neuregulin 1 (NRG1) to transmit its message. NGR1 is already being tested in clinical studies for treating heart failure.

Gabriele D'Uva, PhD, postdoctoral fellow in Tzahor's research group, wanted to know exactly how NRG1 and ERBB2 are involved in heart regeneration. In mice, new heart muscle cells can be added up to a week after birth; newborn mice can regenerate damaged hearts, while seven-day-old mice already cannot. D'Uva and research student Alla Aharonov observed that heart muscle cells called cardiomyocytes that were treated with NRG1 continued to proliferate on the day of birth; but the effect dropped dramatically within a week, even with ample amounts of NRG1. Further investigation showed that the difference between a day and a week was in the amount of ERBB2 on the cardiomyocyte membranes.

The team then created mice in which the gene for ERBB2 was knocked out only in cardiomyocytes. This had a severe impact: The mice had hearts with walls that were thin and balloon-like - a cardiac pathology known as dilated cardiomyopathy. The conclusion was that cardiomyocytes lacking ERBB2 do not divide, even in the presence of NRG1. Next, the team reactivated the ERBB2 protein in adult mouse heart cells, in which cardiomyocytes normally no longer divide. This resulted in extreme cardiomyocyte proliferation and hypertrophy - excessive growth of the individual cardiomyocytes - leading to a giant heart (cardiomegaly) that left little room for blood to enter. "Too little or too much of this protein had a devastating impact on heart function," Tzahor says.

The question then became: If one could activate ERBB2 for just a short period in an adult heart following a heart attack, might it be possible to get the positive results (ie, cardiac cell renewal), without such negative ones as hypertrophy and scarring? Testing this idea, the team found that they could, indeed, activate ERBB2 in mice for a short interval only following an induced heart attack and obtain nearly complete heart regeneration within several weeks. "The results were amazing," Tzahor says. "As opposed to extensive scarring in the control hearts, the ERBB2-expressing hearts had completely returned to their previous state."

Investigation of the regenerative process through live imaging and molecular studies revealed how this happens: The cardiomyocytes "dedifferentiate" - that is, they revert to an earlier form, something between an embryonic and an adult cell, which can then divide and differentiate into new heart cells. In other words, the ERBB2 took the cells back a step to an earlier, embryonic form; and then stopping its activity promoted the regeneration process.

In continuing research, Tzahor and his team began to outline the pathway - the other proteins that respond to the NRG1 message inside the cell.

Tzahor says clinical trials of patients receiving the NRG1 treatment might not be overly successful if ERBB2 levels are not boosted as well. He and his team plan to continue researching this signaling pathway to suggest ways of improving the process, which may, in the future, point to ways of renewing heart cells.

This research, "ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation," appears in Nature Cell Biology.

[Source: Weizmann Institute of Science]
About the Author
  • Judy O'Rourke worked as a newspaper reporter before becoming chief editor of Clinical Lab Products magazine. As a freelance writer today, she is interested in finding the story behind the latest developments in medicine and science, and in learning what lies ahead.
You May Also Like
AUG 21, 2019
Cardiology
AUG 21, 2019
Even Caffeine Sensitive Coffee Drinkers Benefit From Consumption
Despite most evidence suggesting that coffee can be part of a healthy diet, getting that idea into people's heads has proven quite difficult. The idea...
AUG 21, 2019
Cardiology
AUG 21, 2019
How Diets Fail Us
If you’ve ever started a diet plan, you are well aware of how difficult that can be. Most people who successfully lose weight eventually gain it back...
AUG 21, 2019
Cannabis Sciences
AUG 21, 2019
Is Weed Bad For the Heart?
Marijuana has achieved much praise for its purported health benefits discovered in recent years. From slowing down the progression of cancer, to treat...
AUG 21, 2019
Health & Medicine
AUG 21, 2019
Do you sleep with a light or TV on? It may be causing weight gain.
Are you exposed to any artificial light while sleeping? Exposure to artificial light at night could be a risk factor for obesity and weight gain, according...
AUG 21, 2019
Cardiology
AUG 21, 2019
Heart Conditions Amongst The Most Misdiagnosed
There are a massive number of diseases that a person can acquire. This can make the idea of diagnosing a disease accurately seem like a daunting task. Shoc...
AUG 21, 2019
Drug Discovery
AUG 21, 2019
Novel Drug Target for Dilating Microvessels
Medical scientists at Augusta University have discovered a natural occurring chemical that dilates blood vessels dilate as well as signaling larger blood v...
Loading Comments...